Researchers discover genetic ancestry is a critical component of assessing head and neck cancerous tumors

Genetic ancestry plays a key role in determining the behavior of head and neck tumors and may help explain why African-American patients survive for half as long as their counterparts of European ancestry, according to a new review study led by researchers from the University of Maryland School of Medicine's (UMSOM) Institute for Genome Sciences (IGS) and the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).

Analyzing data from 523 patients stored in The Cancer Genome Atlas (TCGA)—the largest biological database for several cancer types—the study, published in Cancer and Metastasis Reviews, identified the important role of genetic differences in association with gene mutations or changes that drive how quickly tumor cells divide and whether they will respond to chemotherapy or spread to other organs.

The researchers found that ancestry, rather than self-identified race, was a stronger predictor of genetic differences between the tumors.

Sign up for Blog Updates